Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3
Frailty progression and sustained nonrobust state increased CVD risk in CKM stages 1 to 3, while frailty improvement had no significant effect. Our findings highlight frailty as a key CVD risk factor, emphasizing the need for early identification and intervention.
Authors
- Jiaxin Shao (ORCID: https://orcid.org/0000-0001-9998-3622)
- Jingwei Lv (ORCID: https://orcid.org/0000-0001-9110-8444)
- Pan Huang (ORCID: https://orcid.org/0000-0003-0098-8517)
- Qianqian Zhu (ORCID: https://orcid.org/0000-0003-2516-6675)
- Jian Teng (ORCID: https://orcid.org/0000-0002-5142-3893)
- Ying Xu (ORCID: https://orcid.org/0000-0001-8497-5937)
- Ashish Verma (ORCID: https://orcid.org/0000-0001-9497-6327)
- Dmitry Abramov (ORCID: https://orcid.org/0000-0003-0571-3109)
- Jian Jin (ORCID: https://orcid.org/0000-0002-1034-5710)
- Hao Zhou (ORCID: https://orcid.org/0009-0009-2297-7932)
- Jiangnan Yao
- Fuman Cai (ORCID: https://orcid.org/0000-0002-9271-5032)
- Qianrong Zheng
- Jianghua Zhou
Institutions
- Boston Medical Center (US)
- Loma Linda University Medical Center (US)
- Loma Linda University (US)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102274
- Citations
- 2
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 2.45